2016 AACE/ACE Guidelines on Type 2 Diabetes Management and New Glycemic Control Agents is organized by Alaska Pharmacists Association (AKPhA). This Conference has been approved for a maximum of 1.5 CPE hours.
Release Date: 2/15/17
Expiration Date: 2/15/20
The incidence of diabetes in the United States has grown rapidly and steadily. Patients with poor glycemic control are at significantly higher risk of developing complications such as neuropathy, blindness, and renal failure. Therapy should include a combination of lifestyle modifications and medication. Several antihyperglycemic agents are available; however,
pharmacologic therapy should be individualized to meet the patient’s needs. Pharmacists have a unique opportunity to aid in the management of diabetes and the associated
At the completion of this activity, the participant will be able to:
• recognize the 2016 AACE/ ACE consensus statement regarding treatment of hyperglycemia associated with diabetes mellitus;
• list lifestyle modifications that contribute to improved glycemic control;
• demonstrate an understanding of various classes of antihyperglycemic agents;
• recognize the mechanism of action of the new antihyperglycemic agents and their respective roles in treating diabetes; and
• identify pertinent prescribing and counseling points associated with the new drugs.
Additional details will be posted as soon as information is available.
Endocrinology, Metabolism and Diabetes